Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.93 and traded as high as $2.95. Mesoblast shares last traded at $2.20, with a volume of 6,144 shares traded.
Mesoblast Price Performance
The stock’s 50 day moving average price is $1.28 and its 200 day moving average price is $0.93.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
See Also
- Five stocks we like better than Mesoblast
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Industrial Products Stocks Investing
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
